A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel C Bowers
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
101 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alberta Hospital
Edmonton, Alberta, Canada
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- the Montreal Children'S Hospital of the Muhc
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, Canada
- Chu de Quebec-Centre Hospitalier de L'Universite Laval (chul)
Québec, Canada
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Golisano Children'S Hospital of Southwest Florida
Fort Myers, Florida, United States
- Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
- Memorial Regional Hospital/joe Dimaggio Children'S Hospital
Hollywood, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Arnold Palmer Hospital for Children
Orlando, Florida, United States
- Nemours Children'S Hospital
Orlando, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Saint Joseph'S Hospital/children'S Hospital-Tampa
Tampa, Florida, United States
- Children'S Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Ascension Saint Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Norton Children'S Hospital
Louisville, Kentucky, United States
- Children'S Hospital New Orleans
New Orleans, Louisiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Feb 2021
- Primary completion
- 30 Dec 2026
- Completion
- 30 Dec 2026
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 300
- Registry id
- NCT04576117
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.